MedTrace Logo

Use of a Mobile-based App for SCD Patients

NCT01833702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2019-07-16

No results posted yet for this study

Summary

The study will seek to enroll 100 sickle cell or thalassemia patients who are age 12 or older who have access to a smartphone or tablet with Internet access daily.

The study will evaluate patient-reported comfort level with using a mobile device to record their pain levels, as well as adherence to recording these levels daily.

The study will track patients' assessment of their pain, actions taken, and outcomes related to pain management and provider involvement.

This study will attempt to collect information about differences in the use of two traditional pain assessment modes (verbal scale and paper) versus the use of a pain assessment tool on a mobile device in the form of a smartphone, tablet, or iPad with an Android or iOS operating system.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jude Jonassaint, RN · Duke University

  • Laura De Castro, MD · Duke University

  • Nirmish Shah, MD · Duke University

Eligibility

Min Age
12 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01833702 on ClinicalTrials.gov